4.5 Article

Understanding the Impact of Sex and Gender in Osteoarthritis: Assessing Research Gaps and Unmet Needs

Journal

JOURNAL OF WOMENS HEALTH
Volume 30, Issue 5, Pages 634-641

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/jwh.2020.8828

Keywords

osteoarthritis; arthritis; chronic pain; sex as a biological variable

Funding

  1. Pfizer, Inc.
  2. Eli Lilly and Company
  3. Teva Pharmaceuticals
  4. Regeneron Pharmaceuticals

Ask authors/readers for more resources

OA affects over 300 million individuals globally, with higher prevalence in women than in men. Women tend to have more severe disease and disability. The Society for Women's Health Research convened a roundtable to review the current state of the science on OA and identify knowledge gaps related to sex and gender, prioritizing areas of need for further attention in research, diagnosis, care, and education.
Osteoarthritis (OA) affects more than 300 million individuals globally, with higher prevalence in women than in men. In addition, OA affects women and men differently, with women demonstrating both increased disease severity and disability. The Society for Women's Health Research convened an interdisciplinary group of expert researchers and clinicians for a roundtable meeting to review the current state of the science on OA and to identify knowledge gaps in the scientific literature, especially as they relate to the topics of sex and gender. The current review summarizes discussions from the roundtable and prioritizes areas of need that warrant further attention in OA research, diagnosis, care, and education. Improvements in basic and clinical research, clinical practice, patient education, and policy are needed to allow for better understanding as to the pathogenesis of sex- and gender-related disparities in OA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available